The PE Ratio as of December 2024 (TTM) for Travere Therapeutics, Inc. (TVTX) is -3.79

According to Travere Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.79. This represents a change of 48.86% compared to the average of -2.55 of the last 4 quarters.

Travere Therapeutics, Inc. (TVTX) Historical PE Ratio (quarterly & annually)

How has TVTX PE Ratio performed in the past?

The mean historical PE Ratio of Travere Therapeutics, Inc. over the last ten years is -6.73. The current -3.79 PE Ratio has changed 5.53% with respect to the historical average. Over the past ten years (40 quarters), TVTX's PE Ratio was at its highest in in the March 2020 quarter at 194.67. The PE Ratio was at its lowest in in the December 2015 quarter at -70.82.

Travere Therapeutics, Inc. (TVTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Travere Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Travere Therapeutics, Inc. (TVTX) Average PE Ratio

How has TVTX PE Ratio performed in the past?

The current PE Ratio of Travere Therapeutics, Inc. (TVTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Travere Therapeutics, Inc. (TVTX) PE Ratio vs. Peers

How is TVTX’s PE Ratio compared to its peers?

Travere Therapeutics, Inc.’s PE Ratio is greater than DICE Therapeutics, Inc. (-22.94), greater than Cytokinetics, Incorporated (-9.99), less than Ventyx Biosciences, Inc. (-1.09), less than Cogent Biosciences, Inc. (-3.53), greater than Nuvalent, Inc. (-24.55), greater than Cerevel Therapeutics Holdings, Inc. (-17.73), greater than Structure Therapeutics Inc. (-12.76), greater than Revolution Medicines, Inc. (-12.93), greater than Akero Therapeutics, Inc. (-8.30), greater than Avidity Biosciences, Inc. (-13.92), less than Protagonist Therapeutics, Inc. (14.68), greater than Stoke Therapeutics, Inc. (-6.20), greater than IDEAYA Biosciences, Inc. (-12.28), less than AnaptysBio, Inc. (-2.44), greater than MeiraGTx Holdings plc (-4.95), less than Keros Therapeutics, Inc. (-3.40), less than Homology Medicines, Inc. (-0.01), greater than Legend Biotech Corporation (-17.76), greater than Vaxcyte, Inc. (-21.22), greater than Apellis Pharmaceuticals, Inc. (-16.45),

Build a custom stock screener for Travere Therapeutics, Inc. (TVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Travere Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Travere Therapeutics, Inc. (TVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Travere Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.